These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35313348)

  • 1. Applying the AFRAID and FRIGHT Clocks to Novel Preclinical Mouse Models of Polypharmacy.
    Mach J; Kane AE; Howlett SE; Sinclair DA; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2022 Jul; 77(7):1304-1312. PubMed ID: 35313348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Polypharmacy with Increasing Drug Burden Index Exacerbates Frailty and Impairs Physical Function, with Effects Attenuated by Deprescribing, in Aged Mice.
    Mach J; Gemikonakli G; Logan C; Vander Wyk B; Allore H; Ekambareshwar S; Kane AE; Howlett SE; de Cabo R; Le Couteur DG; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1010-1018. PubMed ID: 32147704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypharmacy With High Drug Burden Index (DBI) Alters the Gut Microbiome Overriding Aging Effects and Is Reversible With Deprescribing.
    Gemikonakli G; Mach J; Zhang F; Bullock M; Tran T; El-Omar E; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2023 Feb; 78(2):213-222. PubMed ID: 36124741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
    Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
    Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age and life expectancy clocks based on machine learning analysis of mouse frailty.
    Schultz MB; Kane AE; Mitchell SJ; MacArthur MR; Warner E; Vogel DS; Mitchell JR; Howlett SE; Bonkowski MS; Sinclair DA
    Nat Commun; 2020 Sep; 11(1):4618. PubMed ID: 32934233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-designing an intervention to improve the process of deprescribing for older people living with frailty in the United Kingdom.
    Silcock J; Marques I; Olaniyan J; Raynor DK; Baxter H; Gray N; Zaidi STR; Peat G; Fylan B; Breen L; Benn J; Alldred DP
    Health Expect; 2023 Feb; 26(1):399-408. PubMed ID: 36420768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical frailty assessments: Phenotype and frailty index identify frailty in different mice and are variably affected by chronic medications.
    Mach J; Allore H; Gnjidic D; Gemikonakli G; Kane AE; Howlett SE; de Cabo R; Le Couteur D; Hilmer SN
    Exp Gerontol; 2022 May; 161():111700. PubMed ID: 35032570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deprescribing in Older People Approaching End of Life: A Randomized Controlled Trial Using STOPPFrail Criteria.
    Curtin D; Jennings E; Daunt R; Curtin S; Randles M; Gallagher P; O'Mahony D
    J Am Geriatr Soc; 2020 Apr; 68(4):762-769. PubMed ID: 31868920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of deprescribing for older people with frailty and polypharmacy: part one.
    Lyne S
    Nurs Older People; 2023 Oct; 35(5):35-41. PubMed ID: 37670533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
    McIntyre C; McQuillan R; Bell C; Battistella M
    Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes toward deprescribing among adults with heart failure with preserved ejection fraction.
    Navid P; Nguyen L; Jaber D; Zarzuela K; Musse M; Lu Wang M; Requijo T; Kozlov E; Masterson Creber RM; Hilmer SN; Lachs M; Goyal P
    J Am Geriatr Soc; 2021 Jul; 69(7):1948-1955. PubMed ID: 33978239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MedSafer Study-Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial.
    McDonald EG; Wu PE; Rashidi B; Wilson MG; Bortolussi-Courval É; Atique A; Battu K; Bonnici A; Elsayed S; Wilson AG; Papillon-Ferland L; Pilote L; Porter S; Murphy J; Ross SB; Shiu J; Tamblyn R; Whitty R; Xu J; Fabreau G; Haddad T; Palepu A; Khan N; McAlister FA; Downar J; Huang AR; MacMillan TE; Cavalcanti RB; Lee TC
    JAMA Intern Med; 2022 Mar; 182(3):265-273. PubMed ID: 35040926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerobic Exercise Attenuates Frailty in Aging Male and Female C57Bl/6 Mice and Effects Systemic Cytokines Differentially by Sex.
    Bisset ES; Heinze-Milne S; Grandy SA; Howlett SE
    J Gerontol A Biol Sci Med Sci; 2022 Jan; 77(1):41-46. PubMed ID: 34610102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.
    Ailabouni N; Mangin D; Nishtala PS
    Int J Clin Pharm; 2019 Feb; 41(1):167-178. PubMed ID: 30659492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for Identifying Patients for Deprescribing of Blood Pressure Medications in Routine Practice: An Evidence Review.
    Sheppard JP; Benetos A; Bogaerts J; Gnjidic D; McManus RJ
    Curr Hypertens Rep; 2024 May; 26(5):225-236. PubMed ID: 38305846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing in geriatric inpatients is associated with a lower readmission risk: a case control study.
    Hellemans L; Hias J; Walgraeve K; Flamaing J; Spriet I; Tournoy J; Van der Linden L
    Int J Clin Pharm; 2020 Oct; 42(5):1374-1378. PubMed ID: 32803558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
    Komagamine J; Sugawara K; Hagane K
    BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New horizons in deprescribing for older people.
    Woodford HJ; Fisher J
    Age Ageing; 2019 Nov; 48(6):768-775. PubMed ID: 31595290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes towards deprescribing and the influence of health literacy among older Australians.
    Gillespie R; Mullan J; Harrison L
    Prim Health Care Res Dev; 2019 Jun; 20():e78. PubMed ID: 32799987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.